Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,305.00    -15.00 (-0.65%)
Bid:
2,300.00
Ask:
2,305.00
Spread: 5.00 (0.217%)
Market Cap: £3.13b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

16 Sep 2024 07:00

RNS Number : 2184E
RIT Capital Partners PLC
16 September 2024
 

RIT Capital Partners plc (LEI: P31Q1NLTW35JJGHA4667)

 

16 September 2024

 

31 August 2024 Net Asset Value

 

RIT Capital Partners plc ("RIT") announces that its unaudited diluted net asset value ("NAV") as at 31 August 2024 (with debt at fair value) was 2,580p per £1 ordinary share (31 July 2024: 2,560p).

 

August 2024 Commentary and Highlights

 

RIT's NAV per share total return for August 2024 was +0.8%. The increase in the value of our portfolio was driven by positive performance across each of our three strategic investment pillars including Quoted Equities, Private Investments and Uncorrelated Strategies. Our meaningful US dollar position detracted from returns as sterling strengthened by 2.1%. Year to date, RIT's NAV per share total return was +7.2%.

 

RIT's positive performance for August was delivered against a volatile backdrop for global equities in the period. Global equity markets saw a meaningful correction at the start of the month as US unemployment numbers rose, while the Yen strengthened as the Bank of Japan prepared the market for further interest rate hikes. However, calm returned to the markets later in August as the US reported better employment figures and better than expected retail sales. European equities were choppy throughout the month but ended in positive territory, while Chinese domestic equities continued to lag the wider market.

 

Specific highlights for August include:

 

·

An increase in the value of our Quoted Equities book was driven by a range of contributing factors across both direct and underlying managers. This included gains from companies in our Quality theme, as well as ongoing upside from our exposure to specialist managers in Japan which continued to contribute positively to our performance despite the volatility seen in the TOPIX during August. Our portfolio hedges were also additive in the month despite the overall market finishing in the positive.

 

·

Private Investments were a solid contributor during the month, driven by gains from our private funds which saw an increase in Q2 valuations. As of 31 August, 97% of our private funds were held at 30 June reported valuations.

 

·

Investments in Uncorrelated Strategies also contributed positively to our total return for August, driven largely by holdings in credit managers and equity market neutral managers.

 

·

The Board of RIT continued its active buyback programme, generating a further accretive impact on the NAV per share and taking the volume of shares repurchased on behalf of shareholders to approximately 2.2 million for the year to 31 August 2024. Since the start of 2023, the Board has bought back nearly 7% of RIT's issued share capital, representing one of the largest share buybacks in the industry.

 

 

 

 

 

 

 

For more information:

J. Rothschild Capital Management Limited (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.ukinvestorrelations@ritcap.co.uk

 

Numis Securities Limited (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Sofie Brewis

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDXLFFZKLLBBD
Date   Source Headline
3rd Jun 201610:24 amRNSForm 8.5 (EPT/RI)
3rd Jun 201610:23 amRNSForm 8.5 (EPT/RI)
2nd Jun 20163:27 pmRNSForm 8.3 - RIT Capital Partners Plc
2nd Jun 20163:27 pmRNSForm 8.3 - RIT Capital Partners Plc
2nd Jun 20163:12 pmRNSForm 8.3 - [RIT Capital Partners plc]
2nd Jun 201611:45 amRNSForm 8.5 (EPT/RI)
2nd Jun 201611:42 amRNSForm 8.5 (EPT/RI)
2nd Jun 201611:23 amRNSForm 8.3 - RIT Capital Partners Plc
2nd Jun 201610:30 amRNSForm 8.5 (EPT/RI) - RIT Capital Partners PLC
1st Jun 20163:40 pmRNSForm 8.3 - [RIT Capital Partners plc]
1st Jun 20163:32 pmRNSForm 8.3 - RIT Capital Partners Plc
1st Jun 20163:20 pmRNSForm 8.3 - RIT Capital Partners PLC
1st Jun 20163:00 pmRNSForm 8.3 - RIT Capital Partners Plc
1st Jun 20161:34 pmRNSForm 8.3 - RIT Capital Partners Plc
1st Jun 20161:01 pmRNSForm 8.3 - RIT Capital Partners plc
1st Jun 201611:46 amRNSForm 8.3 - RIT Capital Partners PLC
1st Jun 201611:11 amRNSForm 8.5 (EPT/RI)
1st Jun 201611:08 amRNSForm 8.5 (EPT/RI)
1st Jun 201610:45 amRNSForm 8.5 (EPT/RI) - RIT Capital Partners PLC
31st May 20161:17 pmRNSRule 2.10 Announcement
31st May 20161:00 pmRNSRule 2.0 Announcement
31st May 20167:01 amRNSResponse to Press Speculation
20th May 20164:12 pmRNSDirector/PDMR Shareholding
12th May 20167:00 amRNSNet Asset Value(s)
21st Apr 201612:17 pmRNSResult of AGM
14th Apr 20167:00 amRNSNet Asset Value(s)
24th Mar 20164:38 pmRNSDirector/PDMR Shareholding
11th Mar 20167:00 amRNSNet Asset Value(s)
8th Mar 20167:00 amRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSDirector/PDMR Shareholding
1st Mar 20167:00 amRNSFinal Results, Dividend and Directorate
16th Feb 20167:00 amRNSNet Asset Value(s)
3rd Feb 20167:00 amRNSNet Asset Value(s)
31st Dec 201512:24 pmRNSDirector/PDMR Shareholding
14th Dec 20157:00 amRNSNet Asset Value(s)
4th Dec 20152:37 pmRNSDirector/PDMR Shareholding
12th Nov 20157:00 amRNSNet Asset Value(s)
16th Oct 20157:00 amRNSComposition of Board Committee
13th Oct 20157:00 amRNSNet Asset Value(s)
1st Oct 20157:00 amRNSDirectorate Change
10th Sep 20157:00 amRNSNet Asset Value(s)
14th Aug 20157:00 amRNSNet Asset Value(s)
11th Aug 20157:00 amRNSHalf Yearly Report and Dividend
24th Jul 20157:00 amRNSNet Asset Value(s)
16th Jun 20155:49 pmRNSDirector/PDMR Shareholding
11th Jun 20157:00 amRNSNet Asset Value(s)
9th Jun 20153:58 pmRNSHolding(s) in Company
14th May 20157:00 amRNSNet Asset Value(s)
14th May 20157:00 amRNSFixed rate note borrowing
30th Apr 20152:09 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.